These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products. Ludlam CA; Turner ML Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015 [TBL] [Abstract][Full Text] [Related]
7. The safety of human blood: experimental TSE/prion infectivity studies. Cervenakova L Transfus Clin Biol; 2001 Jun; 8(3):260. PubMed ID: 11499973 [No Abstract] [Full Text] [Related]
8. Prions: properties, occurrence, modes of transmission and relevance for blood transfusion and blood derivatives. Yap PL; Leaver HA; Gillon J Vox Sang; 1998; 74 Suppl 2():131-4. PubMed ID: 9704435 [No Abstract] [Full Text] [Related]
9. Implications of notifying donors and recipients. Hewitt PE Vox Sang; 2004 Jul; 87 Suppl 2():1-2. PubMed ID: 15209865 [No Abstract] [Full Text] [Related]
10. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy. Brown P Haemophilia; 2007 Dec; 13 Suppl 5():33-40. PubMed ID: 18078395 [TBL] [Abstract][Full Text] [Related]
11. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation. Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444 [TBL] [Abstract][Full Text] [Related]
12. An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease. Cervia JS; Sowemimo-Coker SO; Ortolano GA; Wilkins K; Schaffer J; Wortham ST Transfus Med Rev; 2006 Jul; 20(3):190-206. PubMed ID: 16787827 [TBL] [Abstract][Full Text] [Related]
13. Blood groups differ on donor deferral. Mitka M JAMA; 2001 Apr; 285(13):1694-5. PubMed ID: 11277807 [No Abstract] [Full Text] [Related]
17. Current strategies to prevent transmission of prions by human plasma derivatives. Burnouf T; Padilla A Transfus Clin Biol; 2006 Nov; 13(5):320-8. PubMed ID: 17254822 [TBL] [Abstract][Full Text] [Related]
18. Adventitious agents from animal-derived raw materials and production systems. Hellman KB; Honstead JP; Vincent CK Dev Biol Stand; 1996; 88():231-4. PubMed ID: 9119142 [No Abstract] [Full Text] [Related]
19. The in vitro bioassay systems for the amplification and detection of abnormal prion PrP(Sc) in blood and tissues. Zhang W; Wu J; Li Y; Carke RC; Wong T Transfus Med Rev; 2008 Jul; 22(3):234-42. PubMed ID: 18572098 [TBL] [Abstract][Full Text] [Related]
20. Creutzfeldt-Jakob disease and blood transfusion. Fernandez Lopez MJ; Van Everbroeck B; Pals P; Martin JJ; Cras P Acta Neurol Belg; 1998 Sep; 98(3):247-51. PubMed ID: 9801705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]